Insider Selling: Calumet (NASDAQ:CLMT) Director Sells $268,000.00 in Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 20,000 shares of the company’s stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $13.40, for a total value of $268,000.00. Following the sale, the director owned 81,959 shares of the company’s stock, valued at approximately $1,098,250.60. The trade was a 19.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Calumet Trading Down 10.8%

Shares of Calumet stock opened at $26.96 on Friday. The business’s fifty day moving average price is $23.06 and its 200 day moving average price is $19.95. Calumet, Inc. has a twelve month low of $7.68 and a twelve month high of $30.35. The stock has a market capitalization of $2.34 billion, a P/E ratio of -69.13 and a beta of 1.24.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings results on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.24. The firm had revenue of ($3,098.50) million for the quarter, compared to analyst estimates of $1.04 billion. The business’s revenue was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.47) earnings per share. As a group, sell-side analysts predict that Calumet, Inc. will post -3.02 EPS for the current year.

Trending Headlines about Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Q4 2025 Results
• Positive Sentiment: FY2025 operational / cash‑flow improvements — management highlighted Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, ~ $100M of cost savings driving free cash flow, and a Montana Renewables expansion on track for Q2 2026; these items materially lower financial risk and support valuation upside longer term. FY2025 Results & Commentary
• Neutral Sentiment: Analyst / preview coverage mixed — several firms updated targets and ratings (Goldman raised its PT; others remain hold/neutral), and the consensus price target (~$22.83) is below the recent trading level, leaving sentiment conflicted. Analyst Coverage Summary
• Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (including a recent 2,000‑share tranche and several 20k tranches earlier), materially trimming his stake; visible insider sales often weigh on investor confidence. Insider Trades Report
• Negative Sentiment: Rising short interest — short positions climbed in February to roughly 6.97M shares (~8.4% of float) with a ~4.4 days‑to‑cover, increasing the potential for continued selling pressure and intraday volatility. Short Interest Data

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CLMT. Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. UBS Group restated a “neutral” rating and set a $26.00 target price on shares of Calumet in a report on Friday, February 13th. HC Wainwright reaffirmed a “buy” rating and set a $33.00 price target on shares of Calumet in a research report on Monday, November 10th. Wall Street Zen lowered Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. Finally, The Goldman Sachs Group upped their target price on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Four equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $22.83.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in Calumet by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,703,040 shares of the oil and gas company’s stock valued at $93,449,000 after purchasing an additional 58,376 shares during the last quarter. Two Seas Capital LP raised its position in shares of Calumet by 56.9% in the 2nd quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock valued at $70,860,000 after purchasing an additional 1,631,098 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Calumet by 112.4% during the 2nd quarter. Geode Capital Management LLC now owns 1,704,670 shares of the oil and gas company’s stock valued at $26,860,000 after buying an additional 901,933 shares during the last quarter. Marshall Wace LLP grew its position in shares of Calumet by 35.8% during the third quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock worth $16,268,000 after buying an additional 234,766 shares in the last quarter. Finally, Bank of America Corp DE grew its position in shares of Calumet by 3.4% during the second quarter. Bank of America Corp DE now owns 609,307 shares of the oil and gas company’s stock worth $9,600,000 after buying an additional 20,110 shares in the last quarter. Institutional investors and hedge funds own 34.41% of the company’s stock.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.